News

The news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the ...
South Africa’s HIV vaccine project lost key funding days before launch, forcing labs to close, workers to be laid off, and ...
There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...
This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
Six months of prevention -- that's how long Lenacapavir, the new drug for HIV prevention lasts.The Food and Drug Administration approved it last month, and desp ...
If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...
The report lays bare the far-reaching consequences of sudden international funding cuts, including halted treatment services, defunded prevention programmes, and widespread health system disruptions.
The Minister’s address was particularly notable for the announcement of a planned rollout of lenacapavir, a biannual ...
Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).